Category Archives: Cancer

Eric Lefkofsky’s Contribution to Better Cancer Care

Home | Cancer | Eric Lefkofsky’s Contribution to Better Cancer Care

Healthcare costs in America have gone up due to the increase of intensity and rates for those services. Due to the increase in population in America, the amount of revenue spent on healthcare has increased. In addition, the aging factor has also played a role in the increase in costs for healthcare services. The type of disease however determines the amount spent on treating the conditions.

Despite all of those costs going up, the Eric Lefkofsky Foundation has played a big role in the easing of such costs. Founded by Eric and his wife Elizabeth, the foundation promotes the cause of researching for the cure of cancer and developing revolutionary therapies that treat patients. At Tempus, Lefkofsky has been able to help physicians come up with custom real-time treatments for cancer patients based on collected data and analyzing molecular therapies rhyming with the patient’s genetic sequence.

American born Eric Paul Lefkofsky is an industrious entrepreneur and one of the industry’s biggest technology icons. Eric co-founded Tempus and serves as CEO. He has also co-founded Groupon, Echo Global Logistics, InnerWorkings, Mediaocean, and Uptake. He is popular for his philanthropic moves with the goal of acquiring a cure for cancer.

The University of Michigan graduated co-founded an internet company known as Starbelly. The company that dealt with the sale of promotional items which led to its quick development. The venture was later sold to Halo industries in 2000. As a result of the sale, Eric joined Halo Industries and served as CEO for a year before creating InnerWorkings. The printing solutions provider experienced a successful first year and continued growing until he left in 2012. Over the years, Lefkofsky developed an interest for the cancer medication and treatment. He was driven to develop custom cancer treatments and even develop a cure. This passion led to the creation of the Tempus, where he serves as chief executive officer.


Oncotarget: A Leading Mutiple Peer-Review Source

Home | Cancer | Oncotarget: A Leading Mutiple Peer-Review Source

Oncotarget: A Leading Multiple Peer-Review Source

Started in 2010, Oncotarget is a peer-reviewed open access medical journal. It publishes papers weekly on a variety of medical and scientific websites online. Oncotarget was initially started to quickly publish multiple peer review papers on oncology and a variety of its aspects. In recent months, however, the journal has begun to offer up works on a wider variety of topics, due to it’s increasing popularity and success.Mikhail Blagosklonny, an expert in cancer and aging, as well as former professor of oncology at the Roswell Park Cancer Institute in New York, serves as Oncotarget’s editor in chief.

He also brings to the journal his years of expertise acquired at New York Medical College, the Medical University of St. Peterburg, and Ordway Research Institute.Oncotarget has an increasing journal impact factor and is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Their mission is to make the results of the scientific process available as quickly and widely as possible while breaking down the barriers between specialties. In this way they hope to improve upon the knowledge and methodology used in treating cancers and help to save more lives.

Oncotarget’s burgeoning success has led it to begin offering reviews on a wider variety of topics including aging, pathology, immunology, microbiology, neurotarget, neuroscience, autophagy, cell death, and circadian rhythm, in addition to oncology. Papers published in these other fields all ascribe to the high level of professionalism that has lead to their growing popularity as a respected multiple peer-review source.The coming months and years will continue to see Oncotarget’s rise among the most respected peer-review scientific journals. It may even find a place situated as the premier source in its fields. Although only time will tell, the future certainly looks bright for Oncotarget and cancer patients worldwide.

What you should know about Oncotarget Journal

Home | Cancer | What you should know about Oncotarget Journal

Cancer affects millions of people around the globe. This is why Oncotarget is an important journal to the world today. This journal allows specialists in Oncology all over the planet to read current news about techniques, medical developments and they can also share their views.With varied topics of interest, every clinician will find the Oncotarget a useful journal. Oncology is a critical field as clinicians strive to manage the conditions, treatments and medications of cancer patients to help them lead more productive lives and reduce side effects. Most families and patients will appreciate a better lifestyle and clinicians would be happy to know that they can contribute to oncology and improve global healthcare quality.

The Oncotarget journal is constantly reviewed every week. Their articles are released on a free access website that guarantees a maximum number of readers. This journal was primarily used for publishing oncology papers. Because of the complex nature of tumor development and the human organism, oncotarget diversified to issue out papers from related fields of pathology, immunology, endocrinology, age-related diseases, cardiology, pharmacology, microbiology, and neuroscience.In 2011, the Thompson Reuter JCR Impact Factor ranked Oncotarget as the best journal, a position they hold to date. This is attributed to their well-organized posts that most readers understand easily. In addition, the chief editors Blagosklonny and Gudkov are passionate about the medical field and only publish current and accurate information.

Journal History

Oncotarget is a weekly medical journal that provides the world with reliable and current information regarding the field of medicine. The journal was established in 2010 as an open access journal by Impact journals with chief editors Mikhail Blagosklonny and Andrei V. Gudkov.The entire journal was primarily devoted to the field of oncology but, has diversified over the years due to a demand for accurate medical data in different areas of medicine. Oncortarget is without a doubt a valuable tool in medical publications today as it contributes current information from Oncologists and clinicians all over the world.Oncortarget appreciates the impact that social media has in the world today. The company has ensured that they have accounts on major social media platforms like Facebook, Youtube, and Twitter. With an online presence, the journal can reach out to millions of audiences in the world.The website works by reviewing posted manuscripts and highlights all the steps in them. The editors will then edit the papers and give reviewers who pass it through the journal on Finally, the chief editors will make a decision and send a message to the original author. Individuals can quickly check the progress of their articles by logging in and confirming its status.